Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition

Biomolecules and Therapeutics

Volumn 23, Issue 1, 2015, Pages 12-18

  Bae, Ok Nam ^a   Noh, Minsoo ^b   Chun, Young Jin ^c   Jeong, Tae Cheon ^d  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c Chung Ang University   (South Korea)

^d Yeungnam University   (South Korea)

Author keywords

Biomarker; Dermal toxicity; Keratinocytic damage; Vascular endothelial growth factor (VEGF)

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; XENOBIOTIC AGENT;

DERMATITIS; HUMAN; KERATINOCYTE; NONHUMAN; PHOTOTOXICITY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; UPREGULATION;

EID: 84920054570     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.102     Document Type: Review

References (86)

1. Alitalo, A. K., Proulx, S. T., Karaman, S., Aebischer, D., Martino, S., Jost, M., Schneider, N., Bry, M. and Detmar, M. (2013) VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res. 73, 4212-4221
2. Bernard, F. X., Morel, F., Camus, M., Pedretti, N., Barrault, C., Garnier, J. and Lecron, J. C. (2012) Keratinocytes under fire of proinflammatory cytokines: Bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. J. Allergy (Cairo) 2012, 718725
3. Ballaun, C., Weninger, W., Uthman, A., Weich, H. and Tschachler, E. (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol. 104, 7-10
4. Bhushan, M., McLaughlin, B., Weiss, J. B. and Griffiths, C. E. (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br. J. Dermatol. 141, 1054-1060
5. Blaudschun, R., Brenneisen, P., Wlaschek, M., Meewes, C. and Scharffetter-Kochanek, K. (2000) The first peak of the UVB irradiationdependent biphasic induction of vascular endothelial growth factor (VEGF) is due to phosphorylation of the epidermal growth factor receptor and independent of autocrine transforming growth factor alpha. FEBS Lett. 474, 195-200
6. Brauchle, M., Funk, J. O., Kind, P. and Werner, S. (1996) Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271, 21793-21797
7. Brenneisen, P., Blaudschun, R., Gille, J., Schneider, L., Hinrichs, R., Wlaschek, M., Eming, S. and Scharffetter-Kochanek, K. (2003) Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem. J. 369, 341-349
8. Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F. and van de Water, L. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379
9. Canavese, M., Altruda, F., Ruzicka, T. and Schauber, J. (2010) Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis-- a possible target for novel therapies? J. Dermatol. Sci. 58, 171-176
10. Cao, Y., E.G. Wang, E. Pal, K. Dutta, S. K. Bar-Sagi, and Mukhopadhyay, D. (2012) VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Res. 72, 3912-3918
11. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395
12. Christensen, T. E., Callis, K. P., Papenfuss, J., Hoffman, M. S., Hansen, C. B., Wong, B., Panko, J. M. and Krueger, G. G. (2006) Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J. Invest. Dermatol. 126, 2397-2403
13. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G. and Levi, B. Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736-741.
14. de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991
15. Detmar, M. (1996) Molecular regulation of angiogenesis in the skin. J. Invest. Dermatol. 106, 207-208
16. Detmar, M. (2000) The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24 Suppl 1, S78-84
17. Detmar, M., Brown, L. F., Berse, B., Jackman, R. W., Elicker, B. M., Dvorak, H. F. and Claffey, K. P. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108, 263-268
18. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B. and Dvorak, H. F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146
19. Detmar, M., Brown, L. F., Schon, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P. and Jain, R. K. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6
20. Detmar, M., Yeo, K. T., Nagy, J. A., Van de Water, L., Brown, L. F., Berse, B., Elicker, B. M., Ledbetter, S. and Dvorak, H. F. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105, 44-50
21. Diaz, B. V., Lenoir, M. C., Ladoux, A., Frelin, C., Demarchez, M. and Michel, S. (2000) Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642-650
22. Elias, P. M., Arbiser, J., Brown, B. E., Rossiter, H., Man, M. Q., Cerimele, F., Crumrine, D., Gunathilake, R., Choi, E. H., Uchida, Y., Tschachler, E. and Feingold, K. R. (2008) Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am. J. Pathol. 173, 689-699
23. Enerbäck, C. (2011) Soluble biomarkers in psoriasis. Eur. J. Dermatol. 21, 844-850
24. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676
25. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. and Siemeister, G. (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15, 669-676
26. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol. Cell. Biol. 16, 4604-4613
27. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G. and Werner, S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270, 12607-12613
28. Geretti, E., Shimizu, A. and Klagsbrun, M. (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39
29. Gille, J., Reisinger, K., Asbe-Vollkopf, A., Hardt-Weinelt, K. and Kaufmann, R. (2000) Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor. J. Invest. Dermatol. 115, 30-36
30. Gille, J., Swerlick, R. A. and Caughman, S. W. (1997) Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J. 16, 750-759
31. Goel, H. L. and Mercurio, A. M. (2013) VEGF targets the tumour cell. Nat. Rev. Cancer 13, 871-882
32. Hänel, K. H., Cornelissen C., Lüscher, B. and Baron, J. M. (2013) Cytokines and the skin barrier. Int. J. Mol. Sci. 14, 6720-6745
33. Hicklin, D. J. and Ellis, L. M. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23, 1011-1027
34. Hirakawa, S., Fujii, S., Kajiya, K., Yano, K. and Detmar, M. (2005) Vascular endothelial growth factor promotes sensitivity to ultraviolet Binduced cutaneous photodamage. Blood 105, 2392-2399
35. Huggenberger, R. and Detmar, M. (2011) The cutaneous vascular system in chronic skin inflammation. J. Investig. Dermatol. Symp. Proc. 15, 24-32
36. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K. and Alitalo, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425
37. Kakurai, M., Demitsu, T., Umemoto, N., Kobayashi, Y., Inoue-Narita, T., Fujita, N., Ohtsuki, M. and Furukawa, Y. (2009) Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes. Br. J. Dermatol. 161, 1232-1238
38. Karkkainen, M. J. and Petrova, T. V. (2000) Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19, 5598-5605
39. Kataru, R. P., Jung, K., Jang, C., Yang, H., Schwendener, R. A., Baik, J. E., Han, S. H., Alitalo, K. and Koh, G. Y. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659
40. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312
41. Kim, H. J. and Kim, T. Y. (2005) Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C. Br. J. Dermatol. 152, 418-425
42. Kozlowska, U., Blume-Peytavi, U., Kodelja, V., Sommer, C., Goerdt, S., Jablonska, S. and Orfanos, C. E. (1998) Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology 196, 89-92
43. Kubo, A., Nagao, K. and Amagai, M. (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 122, 440-447
44. Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. and Iruela-Arispe, M. L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691
45. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
46. Longuet-Perret, I., Schmitt, D. and Viac, J. (1998) Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br. J. Dermatol. 138, 221-224
47. Ma, L., Xue, H. B., Guan, X. H., Shu, C. M., Zhang, J. H. and Yu, J. (2014) Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin. Exp. Immunol. 175, 25-31
48. Man, X. Y., Yang, X. H., Cai, S. Q., Bu, Z. Y. and Zheng, M. (2008) Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J. Cell. Mol. Med. 12, 649-660
49. Man, X. Y., Yang, X. H., Cai, S. Q., Yao, Y. G. and Zheng, M. (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol. Med. 12, 127-136
50. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancerrelated inflammation. Nature 454, 436-444
51. Mildner, M., Weninger, W., Trautinger, F., Ban, J. and Tschachler, E. (1999) UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem. Photobiol. 70, 674-679
52. Nakai, K., Yoneda, K., Moriue, T., Igarashi, J., Kosaka, H. and Kubota, Y. (2009) HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells. J. Dermatol. Sci. 55, 170-178
53. Nielsen, H. J., Christensen, I. J., Svendsen, M. N., Hansen, U., Werther, K., Brunner, N., Petersen, L. J. and Kristensen, J. K. (2002) Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm. Res. 51, 563-567
54. Nissen, N. N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L. and DiPietro, L. A. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152, 1445-1452
55. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371
56. Palacio, S., Schmitt, D. and Viac, J. (1997) Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes. Br. J. Dermatol. 137, 540-544
57. Quail, D. F. and Joyce, J. A. (2013) Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437
58. Rogers, M. S. and D'Amato, R. J. (2006) The effect of genetic diversity on angiogenesis. Exp. Cell Res. 312, 561-574
59. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M. and Carmeliet, P. (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607-648
60. Schiefelbein, D., Seitz, O., Goren, I., Dissmann, J. P., Schmidt, H., Bachmann, M., Sader, R., Geisslinger, G., Pfeilschifter, J. and Frank, S. (2008) Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Mol. Pharmacol. 74, 952-963
61. Schonthaler, H. B., Huggenberger, R., Wculek, S. K., Detmar, M. and Wagner, E. F. (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc. Natl. Acad. Sci. U.S.A. 106, 21264-21269
62. Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H. and Arbeit, J. M. (2008) HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111, 3343-3354
63. Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C. and Roy, S. (2002) Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277, 33284-33290
64. Senger, D. R. (2010) Vascular endothelial growth factor: much more than an angiogenesis factor. Mol. Biol. Cell 21, 377-379
65. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985
66. Shi, V. Y., Bao, L. and Chan, L. S. (2012) Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4- transgenic mouse model. Microcirculation 19, 567-579
67. Skobe, M., Brown, L. F., Tognazzi, K., Ganju, R. K., Dezube, B. J., Alitalo, K. and Detmar, M. (1999) Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDSassociated Kaposi's sarcoma. J. Invest. Dermatol. 113, 1047-1053
68. Suto, K., Yamazaki, Y., Morita, T. and Mizuno, H. (2005) Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1 J. Biol. Chem. 280, 2126-2131
69. Suzuki, T., Hirakawa, S., Shimauchi, T., Ito, T., Sakabe, J., Detmar, M. and Tokura, Y. (2014) VEGF-A promotes IL-17A-producing gammadelta T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells. J. Dermatol. Sci. 74, 116-124
70. Syed, D. N., Afaq, F. and Mukhtar, H. (2012) Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem. Photobiol. 88, 1184-1190
71. Takahashi, H. and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond) 109, 227-241
72. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954
73. Trompezinski, S., Berthier-Vergnes, O., Denis, A., Schmitt, D. and Viac, J. (2004) Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp. Dermatol. 13, 98-105
74. Weidemann, A. K., Crawshaw, A. A., Byrne, E. and Young, H. S. (2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin. Cosmet. Investig. Dermatol. 6, 233-244
75. Weir, L., Robertson, D., Leigh, I. M., Vass, J. K. and Panteleyev, A. A. (2011) Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim. Biophys. Acta 1813, 60-72
76. Weninger, W., Uthman, A., Pammer, J., Pichler, A., Ballaun, C., Lang, I. M., Plettenberg, A., Bankl, H. C., Sturzl, M. and Tschachler, E. (1996) Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab. Invest. 75, 647-657
77. Wilgus, T. A., Matthies, A. M., Radek, K. A., Dovi, J. V., Burns, A. L., Shankar, R. and DiPietro, L. A. (2005) Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am. J. Pathol. 167, 1257-1266
78. Xia, Y. P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D. and Rudge, J. S. (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102, 161-168
79. Yano, K., Brown, L. F. and Detmar, M. (2001) Control of hair growth and follicle size by VEGF-mediated angiogenesis. J. Clin. Invest. 107, 409-417
80. Yano, K., Kadoya, K., Kajiya, K., Hong, Y. K. and Detmar, M. (2005) Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1 Br. J. Dermatol. 152, 115-121
81. Young, H. S., Summers, A. M., Read, I. R., Fairhurst, D. A., Plant, D. J., Campalani, E., Smith, C. H., Barker, J. N., Detmar, M. J., Brenchley, P. E. and Griffiths, C. E. (2006) Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J. Invest. Dermatol. 126, 453-459
82. Yu, X. J., Ren, X. H., Xu, Y. H., Chen, L. M., Zhou, C. L., Li, C. Y. (2010) Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway. Neuropeptides 44, 407-411
83. Zgraggen, S., Ochsenbein, A. M. and Detmar, M. (2013) An important role of blood and lymphatic vessels in inflammation and allergy. J. Allergy (Cairo) 2013, 672381
84. Zhang, Y., Matsuo, H. and Morita, E. (2006) Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch. Dermatol. Res. 297, 425-429
85. Zhu, J. W., Wu, X. J., Lu, Z. F., Luo, D., Cai, S. Q. and Zheng, M. (2013) Role of VEGF receptors in normal and psoriatic human keratinocytes: evidence from irradiation with different UV sources. PLoS One 8, e55463
86. Zhu, J. W., Wu, X. J., Luo, D., Lu, Z. F., Cai, S. Q. and Zheng, M. (2012) Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. Int. J. Biochem. Cell Biol. 44, 246-256.